UK Launches Pioneering Alzheimer's Blood Test Trials

The trials, led by Oxford and University College London, aim to revolutionize dementia diagnosis and treatment.

Thousands of Britons to participate in landmark trials for a new blood test that could significantly improve Alzheimer's diagnosis rates.
The tests, costing about £100 each, seek to identify early-stage proteins linked to Alzheimer's and other dementias, potentially speeding up diagnosis.
Over 900,000 people in the UK currently live with dementia, with the trials aiming to address the nation's 'shocking' diagnosis rates.
Researchers hope the blood tests will facilitate earlier treatment with a new class of drugs, enhancing their effectiveness.
The trials are backed by £5 million from the People’s Postcode Lottery, with results potentially ready for NHS use within five years.